In many cancers, PKM2 is selectively expressed, resulting in the accumulation of phosphoenolpyruvate, and thus redirecting the flow of glycolytic intermediates toward the pentose phosphate pathway (PPP) [15]. The gene discussed is PKM; the disease is cancer.